CClinicalTrials.gg
CompletedNCT00282204Updated Jun 29, 2012

Hypnosis Antenatal Training for Childbirth (HATCh): a Randomised Controlled Trial

A Phase 2/3 interventional study of antenatal hypnosis + audio compact disc on hypnosis and Audio compact disc on hypnosis in Pregnancy and Labor, sponsored by Women's and Children's Hospital, Australia. Completed at 1 site in Australia. Open to female participants. Per ClinicalTrials.gov, last updated 2012-06-29.

Sponsored by Women's and Children's Hospital, Australia · Phase 2/3, Interventional, and Prevention

Phase
Phase 2/3
Study type
Interventional
Enrollment
448
Allocation
Randomized
Sex
Female
01

Study summary

Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Read the detailed description

Background: Although medical interventions play an important role in preserving lives and maternal comfort they have become increasingly routine in normal childbirth. This may increase the risk of associated complications and a less satisfactory birth experience. Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Methods / Design: A single centre, randomised controlled trial using a 3 arm parallel group design in the largest tertiary maternity unit in South Australia. Group 1 participants receive antenatal hypnosis training in preparation for childbirth administered by a qualified hypnotherapist with the use of an audio compact disc on hypnosis for re-enforcement; Group 2 consists of antenatal hypnosis training in preparation for childbirth using an audio compact disc on hypnosis administered by a nurse with no training in hypnotherapy; Group 3 participants continue with their usual preparation for childbirth with no additional intervention. Women > 34 \< 39 weeks gestation, with a singleton, viable fetus, vertex presentation, who are not in active labour or planning a vaginal birth are eligible to participate. Allocation concealment is achieved using telephone randomisation. Participants assigned to hypnosis groups are trained as near as possible to 37 weeks gestation. Group allocations are concealed from treating obstetricians, anaesthetists, midwives and those personnel collecting and analysing data. Our sample size of 135 women / group gives the study 80% power to detect a clinically relevant fall of 20% in the number of women requiring pharmacological analgesia - the primary endpoint. We estimate that approximately 5-10% of women will deliver prior to receiving their allocated intervention. We plan to recruit 150 women / group and perform interim analyses when 150 and 300 participants have been recruited. All participants will be analysed according to the "Intention to treat" principle with comprehensive pre-planned cost- benefit and subgroup analyses.

Discussion: If effective, hypnosis would be a simple, inexpensive way to improve the childbirth experience, reduce complications associated with pharmacological interventions, yield cost savings in maternity care, and provide evidence to guide clinical practice.

02

Conditions studied

  • Pregnancy
  • Labor

Keywords

  • Hypnosis
  • Hypnotherapy
  • Childbirth
  • Analgesia
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • women > 34 \< 39 weeks gestation; singleton, viable fetus, vertex presentation, who are not in active labour (active labour is defined as cervical effacement and dilatation associated with regular uterine contractions) and who are planning a vaginal birth.

Exclusion criteria

Exclusion Criteria:

  • Previous hypnosis preparation for childbirth;
  • poor understanding of English requiring translator;
  • women who are already enrolled in another pregnancy trial where analgesia requirements are an outcome measure;
  • active psychological or psychiatric problems such as: active depression requiring treatment by a psychiatrist;
  • schizophrenia;
  • prior psychosis;
  • severe intellectual disability.
  • Women with pain caused by specific pathological entities such as: congenital neuromuscular disorders; spina bifida; metastatic disease; osteoporosis; rheumatoid arthritis; fractures,are also excluded
04

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
448 participants (actual)

Study arms

  • No intervention
    Control

    Usual care control

  • Experimental
    Hypnosis + CD

    Hypnosis plus audio cd on hypnosis

    Behavioral: antenatal hypnosis + audio compact disc on hypnosis

  • Active comparator
    Audio CD on Hypnosis

    Audio CD on hypnosis sessions weekly on three occasions after 34 weeks gestation

    Behavioral: Audio compact disc on hypnosis

Interventions

  • Behavioralantenatal hypnosis + audio compact disc on hypnosis
  • BehavioralAudio compact disc on hypnosis
05

What researchers measure

Primary outcomes

  1. The use of pharmacological analgesia during labour and childbirth will be collected from the birth register where all analgesia is documented by the attending midwife

    Time frame: Within 24 hours of the birth

Secondary outcomes

  1. 1. Maternal rating of the overall pain experienced during labour and childbirth

    Time frame: Usually within 48 hours or before discharge from hospital

  2. 2. Mode of delivery

    Time frame: Within 24 hours of the birth

  3. 3. Use of oxytocics

    Time frame: Within 24 hours of the birth

  4. 4. Postnatal depression

    Time frame: At 6 weeks and 6 months postnatal

  5. 5. Maternal anxiety

    Time frame: At 6 weeks and 6 months postnatal

  6. 6. Neonatal Apgar score at 5 minutes < 7

    Time frame: within 24 hours of birth

  7. 7. Maternal admission to the High Dependency Unit (HDU) or the Intensive Care Unit (ICU)

    Time frame: within 24 hours of birth

  8. 8. Maternal rating whether the birth experience was. Worse / better / same as expected

    Time frame: within 24 hours of birth

  9. 9. Maternal rating of control during the labour during the birth

    Time frame: within 24 hours of birth

  10. 10. Maternal rating whether the birth was rated positive or negative experience

    Time frame: within 24 hours of birth

  11. 11. Length of neonatal nursery stay

    Time frame: within 24 hours of birth

  12. 12. Length of maternal stay in hospital

    Time frame: within 6 months of the birth

  13. 13. Number of women breast feeding at discharge from hospital and at 6 weeks and 6 months

    Time frame: 6 months after birth

06

Study locations

1 site
  • Women's and Children's Hospital
    Adelaide, South Australia 5006, Australia
07

References and documents

Publications

  • Cyna AM, Andrew MI, Robinson JS, Crowther CA, Baghurst P, Turnbull D, Wicks G, Whittle C. Hypnosis Antenatal Training for Childbirth (HATCh): a randomised controlled trial [NCT00282204]. BMC Pregnancy Childbirth. 2006 Mar 5;6:5. doi: 10.1186/1471-2393-6-5. PubMed 16515709 ↗
08

Registry details

Key details

Study ID
NCT00282204
Lead sponsor
Women's and Children's Hospital, Australia
First posted
Jan 25, 2006
Start date
Dec 2005
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Jun 29, 2012

Study contacts

Marion I Andrew, FANZCA
principal investigator · Women's and Children's Hospital, Australia
Allan M Cyna, FRCA
study director · Women's and Children's Hospital, Australia

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion